Loading clinical trials...
Loading clinical trials...
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder: a Pilot Mechanistic Study
Conditions
Interventions
Semaglutide
Placebo
+1 more
Locations
1
United States
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Start Date
January 15, 2026
Primary Completion Date
January 28, 2029
Completion Date
February 28, 2029
Last Updated
March 19, 2026
NCT07071779
NCT04927143
NCT04721418
NCT05011760
NCT06125054
NCT06701487
Lead Sponsor
The University of Texas Health Science Center, Houston
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions